GlassScriptPhysician profile
Ramella E Barjesteh
NPI 1306116298
$834.55
in general payments reported to CMS, 2019-2025
12 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.30 · 2022: $185 · 2023: $139 · 2024: $127 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $285.70 | 2023-2025 | 2nd Gen Centrimag Primary Console, Amplatzer Amulet |
| Abiomed | $117.60 | 2025 | |
| Novartis Pharmaceuticals Corporation | $88.44 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $82.91 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $76.03 | 2021-2022 | |
| Ucb, INC. | $66.69 | 2021-2022 | |
| Ceribell, INC. | $33.75 | 2024 | Pocket Eeg Device |
| Merck Sharp & Dohme LLC | $28.94 | 2024 | Zerbaxa |
| Advanced Respiratory, INC | $18.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.53 | 2022 | |
| Scpharmaceuticals INC. | $13.17 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramella Barjesteh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.